Option Care Health (OPCH)
(Real Time Quote from BATS)
$29.94 USD
-1.67 (-5.28%)
Updated Aug 5, 2024 02:42 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Price, Consensus and EPS Surprise
OPCH 29.94 -1.67(-5.28%)
Will OPCH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPCH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPCH
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
OPCH vs. ASTH: Which Stock Is the Better Value Option?
OPCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know
Should Value Investors Buy Option Care Health (OPCH) Stock?
Option Care (OPCH) Q2 Earnings and Revenues Top Estimates
Other News for OPCH
Option Care Health Outperforms with Solid Growth and Upgraded Fiscal Outlook
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Qiagen (QGEN) and MiMedx Group (MDXG)
Option Care Health price target raised by $2 at Barrington, here's why
Option Care Health (OPCH) Gets a Buy from Truist Financial
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Teva Pharmaceutical (TEVA) and Option Care Health (OPCH)